Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by zzyy88on Mar 02, 2017 12:13pm

118 Views

Post# 25920091

RE:Stockhouse- Where you can sued for your opinions apparently!

Hi Guys,

Just bought 100K shares of NF very excited. How high do you think this can go?

Momentum - A wholly owned sub means NF owns it. The difference between opinion and slander is that you are claiming they are crooks and NF does not own it when the news release makes it clear as day.

What this means for the stock who knows but thats reality.

GL to all

Bullboard Posts

This battery metals stock is on a path to the global stage